The putative tumor suppressor VILIP-1 counteracts epidermal growth factor-induced epidermal-mesenchymal transition in squamous carcinoma cells

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Schönrath, Katharina ^a   Klein Szanto, Andres J ^b   Braunewell, Karl H ^a,c,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FOX CHASE CANCER CENTER   (United States)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYADENOSINE; CYCLIC AMP; EPIDERMAL GROWTH FACTOR; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SNAIL 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VISININ LIKE PROTEIN 1; NEUROCALCIN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; VSNL1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CARCINOMA CELL; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; UPREGULATION; ANIMAL; CELL MOTION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SKIN TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

GASTROPODA; MURINAE;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CYCLIC AMP; EPIDERMAL GROWTH FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; NEUROCALCIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84859123130     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033116     Document Type: Article

References (51)

1. Thiery JP, Sleeman JP, (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142 nrm1835 [pii];10.1038/nrm1835 [doi].
2. Kalluri R, Weinberg RA, (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428 39104 [pii];10.1172/JCI39104 [doi].
3. Cavallaro U, Christofori G, (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4: 118-132 10.1038/nrc1276 [doi].
4. Tian Z, Guo W, Zhang WG, (2002) [The expression of E-cadherin in oral cancer with different biological behavior]. Shanghai Kou Qiang Yi Xue 11: 350-352 1209 [pii].
5. Deeb G, Wang J, Ramnath N, Slocum HK, Wiseman S, et al. (2004) Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry. Mod Pathol 17: 430-439 10.1038/modpathol.3800041 [doi];3800041 [pii].
6. Dursun P, Yuce K, Usubutun A, Ayhan A, (2007) Loss of epithelium cadherin expression is associated with reduced overall survival and disease-free survival in early-stage squamous cell cervical carcinoma. Int J Gynecol Cancer 17: 843-850 IJG876 [pii];10.1111/j.1525-1438.2007.00876.x [doi].
7. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, et al. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83 10.1038/35000025 [doi].
8. Peinado H, Olmeda D, Cano A, (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428 nrc2131 [pii];10.1038/nrc2131 [doi].
9. Hemavathy K, Ashraf SI, Ip YT, (2000) Snail/slug family of repressors: slowly going into the fast lane of development and cancer. Gene 257: 1-12 S0378-1119(00)00371-1 [pii].
10. Shin SY, Rath O, Zebisch A, Choo SM, Kolch W, et al. (2010) Functional roles of multiple feedback loops in extracellular signal-regulated kinase and Wnt signaling pathways that regulate epithelial-mesenchymal transition. Cancer Res 70: 6715-6724 0008-5472.CAN-10-1377 [pii];10.1158/0008-5472.CAN-10-1377 [doi].
11. Grandoch M, Rose A, ter Braak M, Jendrossek V, Rubben H, et al. (2009) Epac inhibits migration and proliferation of human prostate carcinoma cells. Br J Cancer 101: 2038-2042 6605439 [pii];10.1038/sj.bjc.6605439 [doi].
12. Holz GG, Kang G, Harbeck M, Roe MW, Chepurny OG, (2006) Cell physiology of cAMP sensor Epac. J Physiol 577: 5-15 jphysiol.2006.119644 [pii];10.1113/jphysiol.2006.119644 [doi].
13. Houslay MD, Adams DR, (2010) Putting the lid on phosphodiesterase 4. Nat Biotechnol 28: 38-40 nbt0110-38 [pii];10.1038/nbt0110-38 [doi].
14. Braunewell KH, Klein-Szanto AJ, (2009) Visinin-like proteins (VSNLs): interaction partners and emerging functions in signal transduction of a subfamily of neuronal Ca2+-sensor proteins. Cell Tissue Res 335: 301-316 10.1007/s00441-008-0716-3 [doi].
15. Brackmann M, Schuchmann S, Anand R, Braunewell KH, (2005) Neuronal Ca2+ sensor protein VILIP-1 affects cGMP signalling of guanylyl cyclase B by regulating clathrin-dependent receptor recycling in hippocampal neurons. J Cell Sci 118: 2495-2505 118/11/2495 [pii];10.1242/jcs.02376 [doi].
16. Braunewell KH, Gundelfinger ED, (1997) Low level expression of calcium-sensor protein VILIP induces cAMP-dependent differentiation in rat C6 glioma cells. Neurosci Lett 234: 139-142.
17. Lin L, Braunewell KH, Gundelfinger ED, Anand R, (2002) Functional analysis of calcium-binding EF-hand motifs of visinin-like protein-1. Biochem Biophys Res Commun 296: 827-832 S0006291X02009439 [pii].
18. Mahloogi H, Gonzalez-Guerrico AM, Lopez De CR, Bassi DE, Goodrow T, et al. (2003) Overexpression of the calcium sensor visinin-like protein-1 leads to a cAMP-mediated decrease of in vivo and in vitro growth and invasiveness of squamous cell carcinoma cells. Cancer Res 63: 4997-5004.
19. Gonzalez Guerrico AM, Jaffer ZM, Page RE, Braunewell KH, Chernoff J, et al. (2005) Visinin-like protein-1 is a potent inhibitor of cell adhesion and migration in squamous carcinoma cells. Oncogene 24: 2307-2316 1208476 [pii];10.1038/sj.onc.1208476 [doi].
20. Wickborn C, Klein-Szanto AJ, Schlag PM, Braunewell KH, (2006) Correlation of visinin-like-protein-1 expression with clinicopathological features in squamous cell carcinoma of the esophagus. Mol Carcinog 45: 572-581 10.1002/mc.20201 [doi].
21. Fu J, Fong K, Bellacosa A, Ross E, Apostolou S, et al. (2008) VILIP-1 downregulation in non-small cell lung carcinomas: mechanisms and prediction of survival. PLoS ONE 3: e1698 10.1371/journal.pone.0001698 [doi].
22. Schonrath K, Pan W, Klein-Szanto AJ, Braunewell KH, (2010) Involvement of VILIP-1 (visinin-like protein) and opposite roles of cyclic AMP and GMP signaling in in vitro cell migration of murine skin squamous cell carcinoma. Mol Carcinog 10.1002/mc.20707 [doi].
23. Braunewell KH, Spilker C, Behnisch T, Gundelfinger ED, (1997) The neuronal calcium-sensor protein VILIP modulates cyclic AMP accumulation in stably transfected C6 glioma cells: amino-terminal myristoylation determines functional activity. J Neurochem 68: 2129-2139.
24. Huber O, Kemler R, Langosch D, (1999) Mutations affecting transmembrane segment interactions impair adhesiveness of E-cadherin. J Cell Sci 112 (Pt 23): 4415-4423.
25. de Crane B, van Roy F, Berx G, (2005) Unraveling signalling cascades for the Snail family of transcription factors. Cell Signal 17: 535-547 S0898-6568(04)00221-9 [pii];10.1016/j.cellsig.2004.10.011 [doi].
26. Hoot KE, Lighthall J, Han G, Lu SL, Li A, et al. (2008) Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J Clin Invest 118: 2722-2732 10.1172/JCI33713 [doi].
27. Higashikawa K, Yoneda S, Tobiume K, Saitoh M, Taki M, et al. (2009) DeltaNp63alpha-dependent expression of Id-3 distinctively suppresses the invasiveness of human squamous cell carcinoma. Int J Cancer 124: 2837-2844 10.1002/ijc.24280 [doi].
28. Hudson LG, Choi C, Newkirk KM, Parkhani J, Cooper KL, et al. (2007) Ultraviolet radiation stimulates expression of Snail family transcription factors in keratinocytes. Mol Carcinog 46: 257-268 10.1002/mc.20257 [doi].
29. Lee MY, Chou CY, Tang MJ, Shen MR, (2008) Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin Cancer Res 14: 4743-4750 14/15/4743 [pii];10.1158/1078-0432.CCR-08-0234 [doi].
30. Qiao M, Sheng S, Pardee AB, (2008) Metastasis and AKT activation. Cell Cycle 7: 2991-2996 6784 [pii].
31. Ahmed N, Maines-Bandiera S, Quinn MA, Unger WG, Dedhar S, et al. (2006) Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol 290: C1532-C1542 00478.2005 [pii];10.1152/ajpcell.00478.2005 [doi].
32. Lo HW, Hsu SC, Xia W, Cao X, Shih JY, et al. (2007) Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 67: 9066-9076 67/19/9066 [pii];10.1158/0008-5472.CAN-07-0575 [doi].
33. Lu Z, Ghosh S, Wang Z, Hunter T, (2003) Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 4: 499-515 S1535610803003040 [pii].
34. Ellenrieder V, Hendler SF, Boeck W, Seufferlein T, Menke A, et al. (2001) Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res 61: 4222-4228.
35. Fujimoto K, Sheng H, Shao J, Beauchamp RD, (2001) Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells. Exp Cell Res 266: 239-249 10.1006/excr.2000.5229 [doi];S0014-4827(00)95229-7 [pii].
36. Karmakar S, Das C, (2004) Modulation of ezrin and E-cadherin expression by IL-1beta and TGF-beta1 in human trophoblasts. J Reprod Immunol 64: 9-29 S0165-0378(04)00096-8 [pii];10.1016/j.jri.2004.04.005 [doi].
37. Brown KA, Aakre ME, Gorska AE, Price JO, Eltom SE, et al. (2004) Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res 6: R215-R231 10.1186/bcr778 [doi];bcr778 [pii].
38. Santibanez JF, Olivares D, Guerrero J, Martinez J, (2003) Cyclic AMP inhibits TGFbeta1-induced cell-scattering and invasiveness in murine-transformed keratinocytes. Int J Cancer 107: 715-720 10.1002/ijc.11457 [doi].
39. Yokoyama K, Kamata N, Hayashi E, Hoteiya T, Ueda N, et al. (2001) Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol 37: 65-71 S1368-8375(00)00059-2 [pii].
40. Gan Y, Shi C, Inge L, Hibner M, Balducci J, et al. (2010) Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Oncogene 29: 4947-4958 onc2010240 [pii];10.1038/onc.2010.240 [doi].
41. Bachelder RE, Yoon SO, Franci C, de Herreros AG, Mercurio AM, (2005) Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol 168: 29-33 jcb.200409067 [pii];10.1083/jcb.200409067 [doi].
42. McCawley LJ, Li S, Benavidez M, Halbleib J, Wattenberg EV, et al. (2000) Elevation of intracellular cAMP inhibits growth factor-mediated matrix metalloproteinase-9 induction and keratinocyte migration. Mol Pharmacol 58: 145-151.
43. Mukai M, Nakamura H, Tatsuta M, Iwasaki T, Togawa A, et al. (2000) Hepatoma cell migration through a mesothelial cell monolayer is inhibited by cyclic AMP-elevating agents via a Rho-dependent pathway. FEBS Lett 484: 69-73 S0014-5793(00)02129-3 [pii].
44. Kim A, Son M, Kim KI, Yang Y, Song EY, et al. (2009) Elevation of intracellular cyclic AMP inhibits NF-kappaB-mediated thymosin beta4 expression in melanoma cells. Exp Cell Res 315: 3325-3335 S0014-4827(09)00243-2 [pii];10.1016/j.yexcr.2009.05.024 [doi].
45. Zhang A, Dong Z, Yang T, (2006) Prostaglandin D2 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in MDCK cells. Am J Physiol Renal Physiol 291: F1332-F1342 00131.2006 [pii];10.1152/ajprenal.00131.2006 [doi].
46. Kolosionek E, Savai R, Ghofrani HA, Weissmann N, Guenther A, et al. (2009) Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4. Mol Biol Cell 20: 4751-4765 E09-01-0019 [pii];10.1091/mbc.E09-01-0019 [doi].
47. Lyle KS, Raaijmakers JH, Bruinsma W, Bos JL, de RJ, (2008) cAMP-induced Epac-Rap activation inhibits epithelial cell migration by modulating focal adhesion and leading edge dynamics. Cell Signal 20: 1104-1116 S0898-6568(08)00037-5 [pii];10.1016/j.cellsig.2008.01.018 [doi].
48. Gilcrease MZ, (2007) Integrin signaling in epithelial cells. Cancer Lett 247: 1-25 S0304-3835(06)00211-4 [pii];10.1016/j.canlet.2006.03.031 [doi].
49. Pursiheimo JP, Kieksi A, Jalkanen M, Salmivirta M, (2002) Protein kinase A balances the growth factor-induced Ras/ERK signaling. FEBS Lett 521: 157-164 S0014579302028648 [pii].
50. Hayashi H, Sudo T, (2009) Effects of the cAMP-elevating agents cilostamide, cilostazol and forskolin on the phosphorylation of Akt and GSK-3beta in platelets. Thromb Haemost 102: 327-335 TH08-12-0781 [pii];10.1160/TH08-12-0781 [doi].
51. Iwasaki T, Chen JD, Kim JP, Wynn KC, Woodley DT, (1994) Dibutyryl cyclic AMP modulates keratinocyte migration without alteration of integrin expression. J Invest Dermatol 102: 891-897.